Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?

References

• Ghebreyesus TA Coronavirus should be seen as ‘public enemy number one’, says WHO. Tue 11 Feb 2020 15.36 GMT. Last modified on Wed 12 Feb 2020 01.05 GMT. 2020 [cited 2020 May 20]. https://www.theguardian.com/world/2020/feb/11/coronavirus-vaccine-could-be-ready-in-18-months-says-who
   Google Scholar
• Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. Bmj. 2020;368:m606.
   PubMed Web of Science ®Google Scholar
• BBC. Coronavirus: sharp increase in deaths and cases in Hubei. 2020 [cited 2020 May 20]. https://www.bbc.com/news/world-asia-china-51482994
   Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(75):1730–1741.
   PubMedGoogle Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xiong C, Liu Y, et al. Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020. Pharmacol Res. 2020;157:104821.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
   PubMed Web of Science ®Google Scholar
• Meng Y, Wu P, Lu W, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama. 2020;323(20):2052–2059.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242.
   PubMed Web of Science ®Google Scholar
• Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj. 2015;349:g7647.
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
   PubMed Web of Science ®Google Scholar
• European Commission. A guideline on summary of product characteristics (SmPC). 2009 [cited 2017 Jun 22]. http://ec.europa.eu/health//sites/health/files/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf.
   Google Scholar
• Pedder H, Sarri G, Keeney E, et al. Data extraction for complex meta-analysis (DECiMAL) guide. Syst Rev. 2016;5(1):212.
   PubMedGoogle Scholar
• Dorans KS, Mills KT, Liu Y, et al. Trends in prevalence and control of hypertension according to the 2017 American college of cardiology/American heart association (ACC/AHA) guideline. J Am Heart Assoc. 2018;7(11). DOI:10.1161/JAHA.118.008888.
   PubMed Web of Science ®Google Scholar
• Croft JB, Wheaton AG, Liu Y, et al. Urban-rural county and state differences in chronic obstructive pulmonary disease - United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(7):205–211.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.
   Google Scholar
• National Center for Health Statistics. Tables of summary health statistics for U.S. adults: 2018 national health interview survey. Table A-1c. Centers for Disease Control and Prevention website. 2018 [cited 2020 May 20]. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-1.pdf
   Google Scholar
• National Center for Health Statistics. Tables of summary health statistics for U.S. adults: 2018 national health interview survey. Table A-2c. Centers for Disease Control and Prevention website. 2018 [cited 2020 May 20]. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-2.pdf
   Google Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation. 2018;137(22):2344–2356.
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430.
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523.
   PubMed Web of Science ®Google Scholar
• Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342–352.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771.
   PubMed Web of Science ®Google Scholar
• Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407–418.
   PubMed Web of Science ®Google Scholar
• Jhee JH, Bang S, Lee DG, et al. Comorbidity scoring with causal disease networks. IEEE/ACM Trans Comput Biol Bioinform. 2019;16(5):1627–1634.
   PubMed Web of Science ®Google Scholar
• Blettner M, Sauerbrei W, Schlehofer B, et al. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999;28(1):1–9.
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Dean A, Soe MM. OpenEpi: a web-Based epidemiologic and statistical calculator for public health. Public Health Rep. 2009; 124(3):471–474
   Google Scholar
• Bravata DM, Olkin I. Simple pooling versus combining in meta-analysis. Eval Health Prof. 2001;24(2):218–230.
   PubMed Web of Science ®Google Scholar
• Wells GA, D O’Connell BS, Peterson J, et al. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014 [cited 2020 Sept 16]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• World Health Organization. Proposed working definition of an older person in Africa for the MDS project: Geneva: World Health Organization; 2018 [cited 2020 Jun 15]. https://www.who.int/healthinfo/survey/ageingdefnolder/en/
   Google Scholar
• World Health Organization. Infections and infectious diseases: a manual for nurses and midwives in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2001 [cited 2020 Sep 1]. https://www.euro.who.int/__data/assets/pdf_file/0013/102316/e79822.pdf
   Google Scholar
• To T, Viegi G, Cruz A, et al. A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals. Eur Respir J. 2020;56(1):2001704
   PubMed Web of Science ®Google Scholar
• Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941.
   PubMed Web of Science ®Google Scholar
• Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.
   PubMed Web of Science ®Google Scholar
• Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome. Jama. 2012;307(23):2526–2533.
   PubMed Web of Science ®Google Scholar
• Costa ELV, Amato MBP. The new definition for acute lung injury and acute respiratory distress syndrome: is there room for improvement? Curr Opin Crit Care. 2013;19(1):16–23.
   PubMed Web of Science ®Google Scholar
• Leung JM, Yang CX, Tam A, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5):2000688.
   Web of Science ®Google Scholar
• Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009.
   Web of Science ®Google Scholar
• Halpin DMG, Faner R, Sibila O, et al. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438.
   PubMed Web of Science ®Google Scholar
• Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respiratory Invest. 2020;58(3):155–168.
   PubMed Web of Science ®Google Scholar
• Iwabuchi K, Yoshie K, Kurakami Y, et al. Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: report of three cases. J Infect Chemother: Off J Jpn Soc Chemother. 2020;26(6):625–632.
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Kawase M, Nao N, et al. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. Published online March 12 (preprint). bioRxiv. 2020. doi:10.1101/2020.03.11.987016
   Google Scholar
• Peters MC, Sajuthi S, Deford P, et al. COVID-19 related genes in sputum cells in Asthma: relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020;202(1):83–90
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Segreti A, Bettoncelli G, et al. Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008. Primary Care Respir J: J Gen Pract Airways Group. 2011;20(3):291–298.
   PubMedGoogle Scholar
• Su VY-F, Yang K-Y, Yang Y-H, et al. Use of ICS/LABA combinations or LAMA is associated with a lower risk of acute exacerbation in patients with coexistent COPD and asthma. J Allergy Clin Immunol. 2018;6(6):1927–1935. e3.
   Web of Science ®Google Scholar
• Rottenkolber M, Fischer R, Ibanez L, et al. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial. BMC Pulm Med. 2015;15:55.
   PubMed Web of Science ®Google Scholar
• Maes T, Bracke K, Brusselle GG. COVID-19, Asthma, and inhaled corticosteroids (ICS): another beneficial effect of ICS? Am J Respir Crit Care Med. 2020;202(1):8–10.
   PubMed Web of Science ®Google Scholar